Form 4: Galecto General Counsel Reports Routine Equity Transactions
Insider Transaction Report
Galecto Inc.'s General Counsel, Garrett Winslow, reported the settlement of restricted stock units and a subsequent sale of shares to cover tax obligations.
Summary
- Garrett Winslow, General Counsel of Galecto, Inc. (GLTO), reported transactions involving the company's common stock and restricted stock units (RSUs).
- On July 3, 2025, 680 restricted stock units (RSUs) were settled into common stock, increasing the direct beneficial ownership of common stock by 680 shares.
- Following the RSU settlement, 260 shares of common stock were disposed of at a price of $3.39 per share.
- This sale of 260 shares was mandated by Galecto's election under its 2020 Equity Incentive Plan to cover tax obligations associated with the RSU vesting, and was not a discretionary trade.
- After these transactions, Garrett Winslow directly beneficially owns 1,429 shares of common stock and 2,000 restricted stock units.
- The RSUs were granted on January 3, 2024, with one-third vesting on January 3, 2025, and one-sixth vesting ratably every six months thereafter, contingent on continued employment.
Sentiment
Score: 5
Explanation: The document reports routine insider transactions related to equity compensation and tax obligations, which is neutral in sentiment.
Positives
- The vesting of restricted stock units indicates continued employment and equity compensation for a key executive.
- The RSU program aligns management's interests with shareholder value through equity ownership.
Negatives
- A portion of the vested shares was sold, reducing the direct common stock ownership by the General Counsel, although this was for tax purposes.
Future Outlook
The remaining restricted stock units are scheduled to vest ratably every six months, assuming continued employment through the applicable vesting dates.
Management Comments
- The sale of shares was mandated by the Issuer's election under its 2020 Equity Incentive Plan and does not represent a discretionary trade by the Reporting Person.
Industry Context
This Form 4 filing is a standard disclosure for insider transactions, reflecting routine equity compensation and tax-related share sales common across publicly traded companies, particularly in the biotechnology sector where equity incentives are a significant component of executive compensation.
Stakeholder Impact
- Shareholders: The transaction is a routine insider equity compensation event and is unlikely to have a significant direct impact on shareholders.
- Employees: The RSU vesting schedule highlights the company's equity incentive plan, which can be a positive for employee retention and motivation.
Next Steps
- Future vesting of remaining restricted stock units will occur ratably every six months, contingent on continued employment.
Key Dates
| Date | Description |
|---|---|
| 01/03/2024 | Date restricted stock unit award was granted. |
| 01/03/2025 | Date one-third of the restricted stock units vested. |
| 07/03/2025 | Date of RSU settlement and subsequent share sale. |
| 07/08/2025 | Signature date of the filing. |
Keywords
Galecto, GLTO, Form 4, insider transaction, restricted stock units, RSU, equity compensation, stock sale, tax obligations, General Counsel
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.